In Search of Immunodominant Minor Histocompatibility Antigens

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 171-172

  Perreault, Claude ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; EDITORIAL; GRAFT VERSUS HOST REACTION; HUMAN;

FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE;

EID: 84872567644     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.11.003     Document Type: Editorial

References (14)

1. de Verteuil D., Granados D.P., Thibault P., Perreault C. Origin and plasticity of MHC I-associated self peptides. Autoimmun Rev 2012, 11:627-635.
2. Roopenian D., Choi E.Y., Brown A. The immunogenomics of minor histocompatibility antigens. Immunol Rev 2002, 190:86-94.
3. Spierings E., Hendriks M., Absi L., et al. Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007, 3:e103.
4. Warren E.H., Zhang X.C., Li S., et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood 2012, 120:2796-2806.
5. Pion S., Fontaine P., Baron C., et al. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy. J Clin Invest 1995, 95:1561-1568.
6. Korngold R., Leighton C., Mobraaten L.E., Berger M.A. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens. Biol Blood Marrow Transplant 1997, 3:57-64.
7. Fontaine P., Roy-Proulx G., Knafo L., et al. Adoptive transfer of T lymphocytes targeted to a single immunodominant minor histocompatibility antigen eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001, 7:789-794.
8. Vincent K., Roy D.C., Perreault C. Next-generation leukemia immunotherapy. Blood 2011, 118:2951-2959.
9. Hobo W., Broen K., van der Velden W.J., et al. Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host-disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2012, 19:275-284.
10. + T cells require direct leukemic contact to mediate GVL. Blood 2008, 111:3884-3892.
11. Granados D.P., Yahyaoui W., Laumont C.M., et al. MHC I-associated peptides preferentially derive from transcripts bearing miRNA recognition elements. Blood 2012, 119:e181-e191.
12. Simpson E., Scott D., Chandler P. The male-specific histocompatibility antigen, H-Y: A history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol 1997, 15:39-61.
13. Warren E.H., Fujii N., Akatsuka Y., et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplant with T cells specific for minor histocompatibility antigens. Blood 2010, 115:3869-3878.
14. Perreault C., Roy D.C., Fortin C. Immunodominant minor histocompatibility antigens: The major ones. Immunol Today 1998, 19:69-74.